Form 4: Rocket Lab CEO Peter Beck's Planned Stock Transactions

Rocket Lab CEO Peter Beck reported the acquisition of restricted stock units and subsequent planned sales of common stock to cover tax obligations under a 10b5-1 plan.

Summary

• Peter Beck, CEO and Director of Rocket Lab Corp (RKLB), reported planned transactions under a Rule 10b5-1 plan.
• Acquired 132,426 Restricted Stock Units (RSUs) on November 15, 2025, under the Rocket Lab Corporation 2021 Stock Option and Incentive Plan.
• These RSUs will vest in 1/16 increments, with the first vesting on November 22, 2025, and subsequent vestings on March 1st, May 22nd, August 22nd, or November 22nd thereafter, subject to continuous service.
• Planned to sell a total of 18,857 shares of Common Stock on November 24, 2025, in 'sell-to-cover' transactions to satisfy applicable tax withholding obligations related to RSU vesting.
• The sales occurred at weighted average prices of $40.0247 (4,707 shares), $40.8576 (14,073 shares), and $41.3495 (77 shares).
• Beneficially owns 902,942 shares directly and 2,500,000 shares indirectly through a family trust.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions, including RSU grants and subsequent sell-to-cover sales for tax obligations, which are common for executive compensation and pre-scheduled under a 10b5-1 plan. This is a neutral event.

Positives

• The grant of 132,426 Restricted Stock Units (RSUs) to CEO Peter Beck aligns his interests with long-term shareholder value through equity incentives.
• The transactions are pre-scheduled under a Rule 10b5-1 plan, indicating a structured and transparent approach to managing executive compensation and tax obligations.

Negatives

• The sale of 18,857 shares by the CEO, even for tax purposes, represents a reduction in direct insider ownership.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• 2,500,000 shares are held indirectly by a family trust (Peek Street Equatorial Trustee Limited), where Peter Beck, Kerryn Beck, and Warren Butler serve as directors of the Trustee with shared voting and investment control. Peter Beck disclaims beneficial ownership except to the extent of his pecuniary interest.

Stakeholder Impact

• Shareholders: The RSU grant represents a form of executive compensation, aligning management incentives with company performance. The 'sell-to-cover' sales are a routine part of managing equity compensation and tax liabilities, with minimal direct impact on the company's operations or strategic direction.

Next Steps

• Continued vesting of RSUs on a quarterly schedule (March 1st, May 22nd, August 22nd, November 22nd) following the initial vesting on November 22, 2025.

Key Dates

Recommendation

This Form 4 filing details routine compensation-related transactions for Rocket Lab's CEO, Peter Beck, including the grant of restricted stock units and subsequent 'sell-to-cover' sales to satisfy tax obligations. These transactions are pre-scheduled under a Rule 10b5-1 plan and do not provide new fundamental information about the company's operational performance or strategic direction that would warrant a change in investment recommendation. The indirect ownership through a family trust is also a standard disclosure. Therefore, a 'hold' recommendation is appropriate as the filing does not present new catalysts for significant price movement.

Keywords

RKLB, Rocket Lab, Peter Beck, Form 4, insider trading, stock options, RSU, CEO, director, space, aerospace, 10b5-1 plan